Gemisartan MLN 25 Tablet ER: A Triple Therapy Solution for High Blood Pressure

Gemisartan MLN 25 Tablet ER is a once-daily extended-release tablet containing a unique combination of three potent antihypertensive agents: Cilnidipine (10mg), Metoprolol Succinate (25mg), and Telmisartan (40mg). This multi-faceted approach addresses hypertension by targeting various mechanisms, leading to efficient and sustained blood pressure reduction.

Cilnidipine, a dihydropyridine calcium channel blocker, effectively relaxes blood vessels to lower peripheral vascular resistance. Metoprolol Succinate acts on the beta-adrenergic receptors in the heart and lungs, reducing cardiac workload and preventing strain on the circulatory system. Finally, Telmisartan, an angiotensin II receptor blocker, prevents the action of a hormone that raises blood pressure, offering potent antihypertensive effects.

This innovative formulation provides convenient long-lasting control of blood pressure throughout the day, ensuring optimal therapeutic efficacy with minimal disruptions to daily routines.